Chemo4METPANC Combination Chemotherapy in Patients With Pancreatic Adenocarcinoma
Conditions: Pancreatic Cancer; Adenocarcinoma of the Pancreas; Adenocarcinoma Interventions: Drug: Motixafortide (BL-8040); Drug: Cemiplimab; Drug: Gemcitabine; Drug: Nab paclitaxel Sponsors: Gulam Manji; Regeneron Pharmaceuticals; BioLine Rx Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Chemotherapy | Pancreas | Pancreatic Cancer | Research